Advanced search
Publication Cover
Modern Rheumatology Volume 31, 2021 - Issue 4
Journal homepage
183
Views
10
CrossRef citations to date
0
Altmetric
Rheumatoid Arthritis

A phase 2 study of E6011, an anti-Fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs

Yoshiya Tanakaa The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0807-7139View further author information
ORCID Icon,
Tsutomu Takeuchib Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, JapanView further author information
,
Hisashi Yamanakac Rheumatology, Sanno Medical Center, Tokyo, JapanView further author information
,
Toshihiro Nankid Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, JapanView further author information
,
Hisanori Umeharae Division of Rheumatology and Immunology, Nagahama City Hospital, Shiga, JapanView further author information
,
Nobuyuki Yasudaf KAN Research Institute, Inc, Kobe, JapanView further author information
,
Fumitoshi Tagog Eisai Co. Ltd, Tokyo, JapanView further author information
,
Yasumi Kitaharag Eisai Co. Ltd, Tokyo, JapanView further author information
,
Makoto Kawakubog Eisai Co. Ltd, Tokyo, JapanView further author information
,
Kentaro Toriig Eisai Co. Ltd, Tokyo, JapanView further author information
,
Seiichiro Hojog Eisai Co. Ltd, Tokyo, JapanView further author information
,
Tetsu Kawanof KAN Research Institute, Inc, Kobe, JapanView further author information
&
Toshio Imaif KAN Research Institute, Inc, Kobe, JapanView further author information
 show all
Pages 783-789 | Received 16 Oct 2020, Accepted 22 Dec 2020, Published online: 02 Feb 2021

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.